U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-QSB
(Mark One)
[X] QUARTERLY REPORT UNDER SECTION 13 or 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 1999
[ ] TRANSITION REPORT UNDER SECTION 13 or 15 (d) OF THE
EXCHANGE ACT
For the transition period from _____ to _____
Commission File No. 0-8289
THE ROVAC CORPORATION
(Exact name of small business issuer as
specified in its charter)
Delaware 59-1461320
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
1030 Stafford Street, Rochdale, MA 01542
(Address of principal executive offices)
(508) 892-1121
(Issuer's telephone number)
Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15
(d) of the Exchange Act during the past 12 months (or for such shorter period that the
Registrant was required to file such reports), and, (2) has been subject to such filing
requirements for the past 90 days. Yes NO X
APPLICABLE ONLY TO CORPORATE ISSUERS
State the number of shares outstanding of each of the issuer's classes of common equity,
as of the latest practicable date, February 29, 2000, was 39,943,073 shares of Common
Stock, $0.01 par value.
THE ROVAC CORPORATION |
|
|
|
|
|
Item 1 - Financial Information |
|
|
|
|
|
Condensed Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 1999 |
|
July 31, 1999 |
|
|
|
|
|
(Unaudited) |
|
* |
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
Accounts receivable |
|
|
|
2,070 |
|
700 |
Accounts receivable - other |
|
|
49,880 |
|
61,174 |
Inventory |
|
|
|
|
2,476 |
|
2,003 |
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
54,426 |
|
63,877 |
|
|
|
|
|
|
|
|
Property and equipment |
|
|
|
|
|
Machinery and equipment |
|
|
72,112 |
|
72,112 |
Furniture and fixtures |
|
|
32,336 |
|
30,283 |
Leasehold improvements |
|
|
28,121 |
|
28,121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
132,569 |
|
130,516 |
|
|
|
|
|
|
|
|
Less accumulated depreciation |
|
|
124,184 |
|
123,384 |
|
|
|
|
|
|
|
|
|
Net property and equipment |
|
8,385 |
|
7,132 |
|
|
|
|
|
|
|
|
Patents and patent applications, net of |
|
|
|
|
Accumulated amortization of $16,259 |
|
|
|
|
($15,334 July 31, 1999) |
|
|
68,475 |
|
68,935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
131,286 |
|
139,944 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed financial statements. |
|
|
THE ROVAC CORPORATION |
|
|
|
|
|
Item 1 - Financial Information |
|
|
|
|
|
Condensed Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 31, 1999 |
|
July 31, 1999 |
|
|
|
|
|
(Unaudited) |
|
* |
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Deficiency |
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
Cash overdraft |
|
|
|
$ 1,668 |
|
$ 1,587 |
Notes payable - officer |
|
|
666,614 |
|
665,515 |
Notes payable - other |
|
|
3,250 |
|
3,250 |
Accounts payable: |
|
|
|
|
|
|
|
Trade |
|
|
|
112,411 |
|
113,345 |
|
Parent company |
|
|
784,661 |
|
780,620 |
Accrued expenses |
|
|
|
979,404 |
|
953,871 |
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
2,548,008 |
|
2,518,188 |
|
|
|
|
|
|
|
|
Stockholders' deficiency |
|
|
|
|
|
8% nonvoting preferred stock, $100 par |
|
1,200,000 |
|
1,200,000 |
value. Authorized 25,000 shares, |
|
|
|
|
12,000 shares issued. |
|
|
|
|
|
Common stock, $.01 par value. |
|
|
399,431 |
|
399,431 |
Authorized 40,000,000 shares, issued and |
|
|
|
outstanding 39,943,073 shares |
|
|
|
|
Common stock issuable, $.01 par value, |
|
400 |
|
400 |
40,000 shares |
|
|
|
|
|
|
Additional paid-in capital |
|
|
8,269,432 |
|
8,269,432 |
Accumulated deficit |
|
|
|
(12,285,985) |
|
(12,247,507) |
|
|
|
|
|
|
|
|
|
Total stockholders' deficit |
|
(2,416,722) |
|
(2,378,244) |
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' deficit |
131,286 |
|
139,944 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed financial statements. |
|
|
THE ROVAC CORPORATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations |
|
|
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
Three Months |
|
|
|
|
|
Ended Oct 31 |
Ended Oct 31 |
|
|
|
|
|
1999 |
|
1998 |
Revenues: |
|
|
|
|
|
|
|
Contract Income |
|
|
|
9,000 |
|
9,000 |
Product |
|
|
|
|
7,428 |
|
2,439 |
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
16,428 |
|
11,439 |
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
Cost of sales |
|
|
|
5,541 |
|
3,062 |
General and administrative |
|
|
25,233 |
|
32,594 |
Research and development |
|
|
2,907 |
|
3,881 |
Depreciation and amortization |
|
|
1,725 |
|
1,312 |
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
35,406 |
|
40,849 |
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(18,978) |
|
(29,410) |
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
Interest expense-net |
|
|
|
(19,500) |
|
(19,629) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(19,500) |
|
(19,629) |
|
|
|
|
|
|
|
|
Net Loss |
|
|
|
|
(38,478) |
|
(49,039) |
|
|
|
|
|
|
|
|
Net loss per share of |
|
|
|
|
|
|
common stock |
|
|
|
(0.00) |
|
(0.00) |
|
|
|
|
|
|
|
|
Weighted average number of |
|
|
|
|
|
common shares outstanding |
|
|
|
|
|
and issuable |
|
|
|
39,983,073 |
|
39,983,073 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THE ROVAC CORPORATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows |
|
|
|
|
|
|
Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
Three Months |
|
|
|
|
|
October 31 |
|
October 31 |
|
|
|
|
|
1999 |
|
1998 |
Cash flows from operating activities: |
|
|
|
|
Net loss |
|
|
|
|
(38,478) |
|
(49,039) |
Adjustments to reconcile net loss to net |
|
|
|
|
cash used in operating activities: |
|
|
|
|
Depreciation and amortization |
|
1,725 |
|
1,013 |
(Increase) decrease in assets: |
|
|
|
|
Accounts and loan receivable |
|
9,924 |
|
(3,623) |
Inventory |
|
|
|
(473) |
|
- |
Increase (decrease) in liabilities: |
|
|
|
|
Accounts payable |
|
|
(934) |
|
4,387 |
Accrued expenses |
|
|
25,533 |
|
25,580 |
|
|
|
|
|
|
|
|
|
Total adjustments |
|
|
35,775 |
|
27,356 |
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) |
|
|
|
|
|
operating activities: |
|
|
(2,703) |
|
(21,683) |
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
Costs of patents and patent applications |
|
(465) |
|
(100) |
Acquisition of equipment |
|
|
(2,053) |
|
- |
|
Net cash used in investing activities |
(2,518) |
|
(100) |
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
Proceeds from notes payable - officers |
|
1,099 |
|
(127) |
Advances from parent |
|
|
4,041 |
|
22,706 |
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities |
5,140 |
|
22,579 |
|
|
|
|
|
|
|
|
Net change in cash |
|
|
|
(81) |
|
796 |
|
|
|
|
|
|
|
|
Cash (cash overdraft), beginning of period |
|
(1,587) |
|
(4,830) |
|
|
|
|
|
|
|
|
Cash (cash overdraft), end of period |
|
(1,668) |
|
(4,034) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed financial statements. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THE ROVAC CORPORATION
Notes to Condensed Financial Statements
(Unaudited)
(1) Basis of Presentation
The unaudited financial statements for the three months ended October 31, 1999
and 1998 are unaudited but reflect all adjustments (consisting solely of normal recurring
adjustments) which the Company considers necessary for a fair statement of results for
the interim periods.
The results of operations for three months ended October 31, 1999 and 1998 are
not necessarily indicative of the results for the entire year.
These financial statements supplement and should be read in conjunction with the
Company's audited financial statements for the year ended July 31, 1999 as contained in
the Company's Form 10KSB, as filed with the United States Securities and Exchange
Commission.
(2) Income (Loss) Per Share of Common Stock
Income (loss) per share of common stock as computed is based on the Weighted
average of the number of shares outstanding and issuable during the periods.
PART 1 - FINANCIAL INFORMATION
Item 1. Financial Statements.
See attached
Item 2. Management's discussion and Analysis or Plan of Operation.
(a) Liquidity and Capital Resources
During the quarter, the Company continued to earn revenues in accordance with
its current NIBCO contract. The Company also entered into a dialog with NIBCO to
discuss the possibility of additional thermoplastic licensed markets. There can be no
assurance that these discussions will produce favorable results for the Company.
During the quarter, the Company and its European licensee agreed to suspend its
current European agreement. The Company had been involved in testing with its
European licensee's Sanitary Division. A sale of the European company, changing
management and revolving testing requirements led to a mutual decision to suspend. The
Company is evaluating a new offer to restart testing. There can be no assurance that the
company will commence a new testing agreement with this European company.
The Company continued with discussions and negotiations for financing and
capital sources in order to meet its working capital requirements and manufacturing
costs to implement proposed projects. Management and/or affiliate continues to fund
the capital requirements of the Company, as they become necessary.
(b) Results of Operations for the quarter ended October 31, 1999
The total operating expenses are $35,406 for the quarter ending October 31, 1999
as compared to $40,849 for the corresponding quarter in 1998. The decrease is mainly
attributable to the Company's effort to contain costs during the period.
PART II - OTHER INFORAMTION
Item 1. Legal Proceedings.
None.
Item 2. Changes in Securities.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Submission of Matters to a Vote of Security Holders.
None.
Item 5. Other Information.
None.
Item 6. Exhibits and Reports of Form 8-K.
None.
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
THE ROVAC CORPORATION
(Registrant)
Date: March 13, 2000
Raymond E. Shea, Jr.
Vice President and Treasurer